Lamivudine/tenofovir explained
Lamivudine/tenofovir disoproxil, sold under the brand name Cimduo among others, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS in adults and children weighing more than 35kg (77lb).[2] [3] It contains lamivudine and tenofovir disoproxil. It is taken by mouth.
Lamivudine/tenofovir was approved for medical use in the United States in February 2018.[4]
Further reading
Notes and References
- Web site: Temixys- lamivudine and tenofovir disoproxil fumarate tablet, film coated . DailyMed . 13 February 2022 . 14 February 2022 . https://web.archive.org/web/20220214030036/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a37582e3-ddf6-4058-ba52-7c95f778a3f4 . live .
- Web site: Cimduo- lamivudine and tenofovir disoproxil fumarate tablet, film coated . DailyMed . 22 March 2018 . 26 March 2020 . 15 February 2020 . https://web.archive.org/web/20200215181147/https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a300f04d-118f-4136-aaf3-ddfd00197f86 . live .
- Waters L, Mehta V, Gogtay J, Boffito M . The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIV . Journal of Virus Eradication . 7 . 1 . 100028 . March 2021 . 33598310 . 7868802 . 10.1016/j.jve.2021.100028 .
- Web site: Drug Approval Package: Cimduo (lamivudine and tenofovir disoproxil fumarate) . U.S. Food and Drug Administration (FDA) . 27 November 2018 . 26 March 2020 . 26 March 2020 . https://web.archive.org/web/20200326063549/https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/022141Orig1s000TOC.cfm . live .